Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?

Liver Transplantation

Volumn 17, Issue SUPPL. 2, 2011, Pages

  Grant, David ^a,b,e   Fisher, Robert A ^b   Abecassis, Michael ^c   McCaughan, Geoffrey ^d   Wright, Linda ^a   Fan, Sheung Tat ^e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; END STAGE LIVER DISEASE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; NOTE; ORGAN DONOR; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; DONOR SELECTION; EVIDENCE-BASED MEDICINE; HEALTH STATUS INDICATORS; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053257977     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22348     Document Type: Note

References (21)

1. Kulik L, Abecassis M,. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127 (suppl 1): S277-S282. (Pubitemid 39423397)
2. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG,. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005; 11: 1265-1272. (Pubitemid 41511942)
3. Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al.; for A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7: 1601-1608. (Pubitemid 46776250)
4. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J,. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78-86. (Pubitemid 46142736)
5. Di Sandro S, Slim AO, Giacomoni A, Lauterio A, Mangoni I, Aseni P, et al. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant Proc 2009; 41: 1283-1285.
6. Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, et al. Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 2009; 15: 1861-1866.
7. Chen JA, Shi M, Li JQ, Qian CN,. Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration. Hepatol Int 2010; 4: 537-547.
8. Roberts JP, Venook A, Kerlan R, Yao F,. Hepatocellular carcinoma: ablate and wait versus rapid transplantation. Liver Transpl 2010; 16: 925-929.
9. Chao SD, Roberts JP, Farr M, Yao FY,. Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma. Am J Transplant 2007; 7: 1594-1600. (Pubitemid 46776249)
10. Volk ML, Vijan S, Marrero JA,. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008; 8: 839-846. (Pubitemid 351347750)
11. Lee S, Ahn C, Ha T, Moon D, Choi K, Song G, et al. Liver transplantation for hepatocellular carcinoma: Korean experience. J Hepatobiliary Pancreat Sci 2010; 17: 539-547.
12. Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008; 14: 935-945. (Pubitemid 352003892)
13. Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S, Uemoto S,. Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant 2009; 9: 2362-2371.
14. Sugawara Y, Tamura S, Makuuchi M,. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007; 25: 310-312. (Pubitemid 350014958)
15. Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006; 12: 1260-1267. (Pubitemid 44194595)
16. Yao FY, Kerlan RK Jr, Hirose R, Davern TJ III, Bass NM, Feng S, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008; 48: 819-827.
17. D'Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl 2009; 15: 1278-1287.
18. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al.; for Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
19. Spital A, Taylor JS,. Primum non nocere and living organ donation: a response to Dr. Klintmalm. Am J Transplant 2008; 8: 1352-1353. (Pubitemid 351763690)
20. Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, et al. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation 2006; 81: 1373-1385. (Pubitemid 43847145)
21. Yao FY,. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant 2008; 8: 1982-1989.